Literature DB >> 31186843

Is there still a role for liver biopsy in managing hepatitis C virus infections?

Syed-Mohammed R Jafri1, Stuart C Gordon1.   

Abstract

Entities:  

Year:  2012        PMID： 31186843      PMCID： PMC6499258          DOI： 10.1002/cld.30

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


× No keyword cloud information.
  45 in total

1.  Prevention of recurrent hepatitis C after liver transplantation with early interferon and ribavirin treatment.

Authors:  V Mazzaferro; A Tagger; M Schiavo; E Regalia; A Pulvirenti; M L Ribero; J Coppa; R Romito; L Burgoa; N Zucchini; T Urbanek; F Bonino
Journal:  Transplant Proc       Date:  2001 Feb-Mar       Impact factor: 1.066

Review 2.  National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C: 2002--June 10-12, 2002.

Authors: 
Journal:  Hepatology       Date:  2002-11       Impact factor: 17.425

3.  Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis.

Authors:  E J Heathcote; M L Shiffman; W G Cooksley; G M Dusheiko; S S Lee; L Balart; R Reindollar; R K Reddy; T L Wright; A Lin; J Hoffman; J De Pamphilis
Journal:  N Engl J Med       Date:  2000-12-07       Impact factor: 91.245

4.  Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis.

Authors:  L F Hourigan; G A Macdonald; D Purdie; V H Whitehall; C Shorthouse; A Clouston; E E Powell
Journal:  Hepatology       Date:  1999-04       Impact factor: 17.425

5.  Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study.

Authors:  F Imbert-Bismut; V Ratziu; L Pieroni; F Charlotte; Y Benhamou; T Poynard
Journal:  Lancet       Date:  2001-04-07       Impact factor: 79.321

6.  Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection.

Authors:  Arie Regev; Mariana Berho; Lennox J Jeffers; Clara Milikowski; Enrique G Molina; Nikolaos T Pyrsopoulos; Zheng-Zhou Feng; K Rajender Reddy; Eugene R Schiff
Journal:  Am J Gastroenterol       Date:  2002-10       Impact factor: 10.864

7.  Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity.

Authors:  L E Adinolfi; M Gambardella; A Andreana; M F Tripodi ; R Utili; G Ruggiero
Journal:  Hepatology       Date:  2001-06       Impact factor: 17.425

8.  Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model.

Authors:  Xavier Forns; Sergi Ampurdanès; Josep M Llovet; John Aponte; Llorenç Quintó; Eva Martínez-Bauer; Miquel Bruguera; Jose Maria Sánchez-Tapias; Juan Rodés
Journal:  Hepatology       Date:  2002-10       Impact factor: 17.425

9.  A 10-year experience of liver transplantation for hepatitis C: analysis of factors determining outcome in over 500 patients.

Authors:  R M Ghobrial; R Steadman; J Gornbein; C Lassman; C D Holt; P Chen; D G Farmer; H Yersiz; N Danino; E Collisson; A Baquarizo; S S Han; S Saab; L I Goldstein; J A Donovan; K Esrason; R W Busuttil
Journal:  Ann Surg       Date:  2001-09       Impact factor: 12.969

10.  Steatosis accelerates fibrosis development over time in hepatitis C virus genotype 3 infected patients.

Authors:  Johan Westin; Hans Nordlinder; Martin Lagging; Gunnar Norkrans; Rune Wejstål
Journal:  J Hepatol       Date:  2002-12       Impact factor: 25.083
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.